The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.
Open accessAbstract
Vaccinia virus, no longer required for immunization against smallpox, now serves as a unique vector for expressing genes within the cytoplasm of mammalian cells. As a research tool, recombinant vaccinia viruses are used to synthesize and analyze the structure-function relationships of proteins, determine the targets of humoral and cell-mediated immunity, and investigate the types of immune response needed for protection against specific infectious diseases and cancer. The vaccine potential of recombinant vaccinia virus has been realized in the form of an effective oral wild-life rabies vaccine, although no product for humans has been licensed. A genetically altered vaccinia virus that is unable to replicate in mammalian cells and produces diminished cytopathic effects retains the capacity for high-level gene expression and immunogenicity while promising exceptional safety for laboratory workers and potential vaccine recipients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Fuerst, T. R., Niles, E. G., Studier, F. W., & Moss, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8122 · Cited by 2,089
Self-citation(1988) · World Health Organization eBooks · Cited by 1,574
Elwood, J. M. (1989) · Journal of Epidemiology and Community Health · doi:10.1136/jech.43.1.92 · Cited by 1,412
Chakrabarti, S., Brechling, K., & Moss, B. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.12.3403 · Cited by 777
Self-citationRich, D. P., Anderson, M. P., Gregory, R. J., Cheng, S. H., Paul, S., Jefferson, D. M., McCann, J. D., Klinger, K. W., Smith, A. E., & Welsh, M. J. (1990) · Nature · doi:10.1038/347358a0 · Cited by 708
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
Mackett, M., Smith, G. L., & Moss, B. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.23.7415 · Cited by 646
Self-citationMackett, M., Smith, G. L., & Moss, B. (1984) · Journal of Virology · doi:10.1128/jvi.49.3.857-864.1984 · Cited by 644
Self-citationInfectious rabies viruses from cloned cDNA.
Schnell, M. J., Mebatsion, T., & Conzelmann, K. K. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06739.x · Cited by 641
Nonreplicating vaccinia vector efficiently expresses recombinant genes.
Sutter, G., & Moss, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10847 · Cited by 600
Self-citationComplications of Smallpox Vaccination, 1968: National Surveillance in the United States
Lane, J. M., Ruben, F. L., Neff, J. M., & Millar, J. D. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911272812201 · Cited by 545
Yewdell, J. W., Bennink, J. R., Smith, G. L., & Moss, B. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1785 · Cited by 521
Self-citationMorrison, L. A., Lukacher, A. E., Braciale, V. L., Fan, D. P., & Braciale, T. J. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.4.903 · Cited by 507
Panicali, D., & Paoletti, E. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.16.4927 · Cited by 497
Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones.
Whelan, S. P., Ball, L. A., Barr, J. N., & Wertz, G. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8388 · Cited by 484
Meyer, H., Sutter, G., & Mayr, A. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-5-1031 · Cited by 474
The role of interleukin-6 in mucosal IgA antibody responses in vivo
Ramsay, A. J., Husband, A. J., Ramshaw, L. A., Bao, S., Matthaei, K. I., Koehler, G., & Kopf, M. (1994) · Science · doi:10.1126/science.8160012 · Cited by 454
Buller, R. M. L., Smith, G. L., Cremer, K., Notkins, A. L., & Moss, B. (1985) · Nature · doi:10.1038/317813a0 · Cited by 453
Self-citationVaccinia Virus: A Tool for Research and Vaccine Development
Moss, B. (1991) · Science · doi:10.1126/science.2047875 · Cited by 451
Self-citationCollins, P. L., Hill, M. G., Camargo, E., Grosfeld, H., Chanock, R. M., & Murphy, B. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11563 · Cited by 450
Actin-based motility of vaccinia virus
Cudmore, S., Cossart, P., Griffiths, G., & Way, M. (1995) · Nature · doi:10.1038/378636a0 · Cited by 425
Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes.
Fuerst, T. R., Earl, P. L., & Moss, B. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.7.2538 · Cited by 412
Self-citationStructure of vaccinia virus late promoters
Davison, A. J., & Moss, B. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90108-3 · Cited by 401
Self-citationElroy-Stein, O., Fuerst, T. R., & Moss, B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6126 · Cited by 401
Self-citationAssembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network
Schmelz, M., Sodeik, B., Ericsson, M., Wolffe, E. J., Shida, H., Hiller, G., & Griffiths, G. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.130-147.1994 · Cited by 385
A new cationic liposome reagent mediating nearly quantitative transfection of animal cells.
Rose, J. K., Buonocore, L., & Whitt, M. A. (1991) · PubMed · Cited by 385
Wiktor, T. J., Macfarlan, R. I., Reagan, K. J., Dietzschold, B., Curtis, P. J., Wunner, W. H., Kieny, M. P., Lathe, R., Lecocq, J. P., & Mackett, M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7194 · Cited by 382
Significance of Extracellular Enveloped Virus in the in vitro and in vivo Dissemination of Vaccinia
Payne, L. G. (1980) · Journal of General Virology · doi:10.1099/0022-1317-50-1-89 · Cited by 342
Townsend, A., Bastin, J., Gould, K., Brownlee, G., Andrew, M., Coupar, B., Boyle, D., Chan, S., & Smith, G. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.4.1211 · Cited by 327
Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA
Smith, G. L., & Moss, B. (1983) · Gene · doi:10.1016/0378-1119(83)90163-4 · Cited by 324
Self-citationFalkner, F. G., & Moss, B. (1988) · Journal of Virology · doi:10.1128/jvi.62.6.1849-1854.1988 · Cited by 316
Self-citationLarge-scale eradication of rabies using recombinant vaccinia-rabies vaccine
Brochier, B., Kiény, M. P., Costy, F., Coppens, P., Bauduin, B., Lecocq, J. P., Languet, B., Chappuis, G., Desmettre, P., Afiademanyo, K. M., et al. (1991) · Nature · doi:10.1038/354520a0 · Cited by 292
Live recombinant vaccinia virus protects chimpanzees against hepatitis B
Moss, B., Smith, G. L., Gerin, J. L., & Purcell, R. H. (1984) · Nature · doi:10.1038/311067a0 · Cited by 281
Self-citationHIV-1 Reverse Transcriptase Is a Target for Cytotoxic T Lymphocytes in Infected Individuals
Walker, B. D., Flexner, C., Paradis, T. J., Fuller, T. C., Hirsch, M. S., Schooley, R. T., & Moss, B. (1988) · Science · doi:10.1126/science.2451288 · Cited by 267
Self-citationBroyles, S. S. (2003) · Journal of General Virology · doi:10.1099/vir.0.18942-0 · Cited by 252
Isaacs, S. N., Kotwal, G. J., & Moss, B. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.628 · Cited by 243
Self-citationOral vaccination of the fox against rabies using a live recombinant vaccinia virus
Blancou, J., Kieny, M. P., Lathe, R., Lecocq, J. P., Pastore, P. P., Soulebot, J. P., & Desmettre, P. (1986) · Nature · doi:10.1038/322373a0 · Cited by 241
Rupprecht, C. E., Wiktor, T. J., Johnston, D. H., Hamir, A. N., Dietzschold, B., Wunner, W. H., Glickman, L. T., & Koprowski, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.20.7947 · Cited by 235
Earl, P. L., Koenig, S., & Moss, B. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.31-41.1991 · Cited by 229
Self-citationHébert, L. J., Maltais, D. B., Lepage, C., Saulnier, J., Crête, M., & Perron, M. (2011) · Pediatric Physical Therapy · doi:10.1097/pep.0b013e318227ccff · Cited by 227
Non‐replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase
Sutter, G., Ohlmann, M., & Erfle, V. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00843-x · Cited by 226
Immunoglobulin A mediation of murine nasal anti-influenza virus immunity
Renegar, K. B., & Small, P. A. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.2146-2148.1991 · Cited by 225
Vaccinia Virus Recombinants: Expression of VSV Genes and Protective Immunization of Mice and Cattle
Mackett, M., Yilma, T., Rose, J. K., & Moss, B. (1985) · Science · doi:10.1126/science.2981435 · Cited by 221
Self-citationPrevention of vaccinia virus infection in imiminodeficient mice by vector-directed IL-2 expression
Flexner, C., Hügin, A., & Moss, B. (1987) · Nature · doi:10.1038/330259a0 · Cited by 213
Self-citationKantor, J., Irvine, K., Abrams, S., Kaufman, H., Dipietro, J., & Schlom, J. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.14.1084 · Cited by 210
Recombinant fowlpox virus inducing protective immunity in non-avian species
TAYLOR, J., WEINBERG, R., LANGUET, B., DESMETTRE, P., & PAOLETTI, E. (1988) · Vaccine · doi:10.1016/0264-410x(88)90100-4 · Cited by 205
Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection
Ramshaw, I. A., Andrew, M. E., Phillips, S. M., Boyle, D. B., & Coupar, B. E. H. (1987) · Nature · doi:10.1038/329545a0 · Cited by 193
Elroy-Stein, O., & Moss, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6743 · Cited by 190
Self-citationJaraquemada, D., Marti, M., & Long, E. O. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.947 · Cited by 187
Selection of recombinant vaccinia viruses on the basis of plaque formation
Blasco, R., & Moss, B. (1995) · Gene · doi:10.1016/0378-1119(95)00149-z · Cited by 182
Self-citationImmunisation with canarypox virus expressing rabies glycoprotein
Cadoz, M., Meignier, B., Plotkin, S., Strady, A., Taylor, J., Tartaglia, J., & Paoletti, E. (1992) · The Lancet · doi:10.1016/0140-6736(92)92027-d · Cited by 182
Ashorn, P. A., Berger, E. A., & Moss, B. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2149-2156.1990 · Cited by 180
Self-citationEfficacy studies on a canarypox-rabies recombinant virus
TAYLOR, J., TRIMARCHI, C., WEINBERG, R., LANGUET, B., GUILLERMIN, F., DESMETTRE, P., & PAOLETTI, E. (1991) · Vaccine · doi:10.1016/0264-410x(91)90152-v · Cited by 165
Weir, J. P., Bajszár, G., & Moss, B. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.4.1210 · Cited by 158
Self-citationAlexander, W. A., Moss, B., & Fuerst, T. R. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2934-2942.1992 · Cited by 158
Self-citationTaylor, J., Weinberg, R., Tartaglia, J., Richardson, C., Alkhatib, G., Briedis, D. J., Appel, M. J. G., Norton, E. K., & Paoletti, E. (1992) · Virology · doi:10.1016/0042-6822(92)90321-f · Cited by 150
Pialoux, G., Excler, J., Rivière, Y., Gonzalez-Canali, G., FEUILLIE, V., Coulaud, P., Gluckman, J. C., Matthews, T. J., Meignier, B., Kiény, M.-P., et al. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.373 · Cited by 147
Cell proliferative response to vaccinia virus is mediated by VGF
Buller, R. M. L., Chakrabarti, S., Moss, B., & Fredricksont, T. (1988) · Virology · doi:10.1016/0042-6822(88)90635-6 · Cited by 133
Self-citationWard, G. A., Stover, C. K., Moss, B., & Fuerst, T. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6773 · Cited by 131
Self-citationRao, J. B., Chamberlain, R. S., Bronte, V., Carroll, M. W., Irvine, K. R., Moss, B., Rosenberg, S. A., & Restifo, N. P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3357 · Cited by 125
Self-citationMolecular genetics of vaccinia virus: demonstration of marker rescue.
Nakano, E., Panicali, D., & Paoletti, E. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.5.1593 · Cited by 125
High-voltage electron microscope study of the release of vaccinia virus from whole cells
Stokes, G. V. (1976) · Journal of Virology · doi:10.1128/jvi.18.2.636-643.1976 · Cited by 122
Roth, J., Dittmer, D. P., Réa, D., Tartaglia, J., Paoletti, E., & Levine, A. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4781 · Cited by 118
Construction of recombinant fowlpox viruses as vectors for poultry vaccines
Boyle, D. B., & Coupar, B. E. H. (1988) · Virus Research · doi:10.1016/0168-1702(88)90075-5 · Cited by 117
Elango, N., Prince, G. A., Murphy, B. R., Venkatesan, S., Chanock, R. M., & Moss, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1906 · Cited by 116
Self-citationImmunodeficient mice recover from infection with vaccinia virus expressing interferon‐γ
Kohonen‐Corish, M. R. J., King, N. J. C., Woodhams, C. E., & Ramshaw, I. A. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200123 · Cited by 115
Karupiah, G., Blanden, R. V., & Ramshaw, I. A. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.5.1495 · Cited by 106
Tumour prevention and rejection with recombinant vaccinia
Lathe, R., Kiény, M. P., GERLINGER, P., Clertant, P., Guizani, I., Cuzin, F., & Chambon, P. (1987) · Nature · doi:10.1038/326878a0 · Cited by 103
Karupiah, G., Coupar, B. E. H., Andrew, M. E., Boyle, D. B., Phillips, S., Müllbacher, A., Blanden, R. V., & Ramshaw, I. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.1.290 · Cited by 101
Malvoisin, E., & Wild, F. T. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.5160-5162.1990 · Cited by 99
Bernards, R., Destree, A. T., McKenzie, S. J., Gordon, E., Weinberg, R. A., & Panicali, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6854 · Cited by 98
Esposito, J. J., Knight, J. C., Shaddock, J. H., Novembre, F. J., & Baer, G. Μ. (1988) · Virology · doi:10.1016/0042-6822(88)90692-7 · Cited by 98
Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor.
Moore, J. B., & Smith, G. L. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05251.x · Cited by 96
Recombinant Vaccinia Viruses As Vectors for Studying T Lymphocyte Specificity and Function
Bennink, J. R., & Yewdell, J. W. (1990) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-75605-4_6 · Cited by 94
Kulkarni, A. B., Morse, H. C., Bennink, J. R., Yewdell, J. W., & Murphy, B. R. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.4086-4092.1993 · Cited by 94
Cochran, M. A., Mackett, M., & Moss, B. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.19 · Cited by 84
Self-citationCostimulation enhances the active immunotherapy effect of recombinant anticancer vaccines.
Chamberlain, R. S., Carroll, M. W., Bronte, V., Hwu, P., Warren, S., Yang, J. C.-H., Nishimura, M. I., Moss, B., Rosenberg, S. A., & Restifo, N. P. (1996) · PubMed · Cited by 82
Self-citationInducible gene expression from vaccinia virus vectors
Rodrígúez, J. F., & Smith, G. L. (1990) · Virology · doi:10.1016/0042-6822(90)90477-9 · Cited by 78
A poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells.
Patel, D. D., Ray, C. A., Drucker, R. P., & Pickup, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9431 · Cited by 69
Kulkarni, A. B., Connors, M., Firestone, C.-Y., Morse, H. C., & Murphy, B. R. (1993) · Journal of Virology · doi:10.1128/jvi.67.2.1044-1049.1993 · Cited by 67
Fuerst, T. R., Fernández, M. P., & Moss, B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2549 · Cited by 67
Self-citationProtection of chickens from lethal influenza infection by vaccinia-expressed hemagglutinin
Chambers, T. M., Kawaoka, Y., & Webster, R. G. (1988) · Virology · doi:10.1016/0042-6822(88)90103-1 · Cited by 59
Ramsay, A. J., & Kohonen‐Corish, M. R. J. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231215 · Cited by 56
Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses
Isaacs, S. N., Kotwal, G. J., & Moss, B. A. (1990) · Virology · doi:10.1016/0042-6822(90)90367-z · Cited by 53
Self-citationInfection of frog neurons with vaccinia virus permits in vivo expression of foreign proteins
Wu, G., Zou, D., Koothan, T., & Cline, H. T. (1995) · Neuron · doi:10.1016/0896-6273(95)90211-2 · Cited by 49
Polydefkis, M. J., Koenig, S., Flexner, C. W., Obah, E. A., Gebo, K. A., Chakrabarti, S., Earl, P. L., Moss, B., & Siliciano, R. F. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.3.875 · Cited by 48
Self-citationLetellier, C., Burny, A., & Meulemans, G. (1991) · Archives of Virology · doi:10.1007/bf01311302 · Cited by 45
Enteric immunization of mice against influenza with recombinant vaccinia.
Meitin, C. A., Bender, B. S., & Small, P. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11187 · Cited by 43
Vaccinia virus transfection of hippocampal slice neurons
Pettit, D. L., Koothan, T., Liao, D., & Malinow, R. (1995) · Neuron · doi:10.1016/0896-6273(95)90212-0 · Cited by 39
Kanesaki, T., Murphy, B. R., Collins, P. L., & Ogra, P. L. O. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.657-663.1991 · Cited by 37
Poxvirus deletion mutants: virulence and immunogenicity
Edwards, K. M., Andrews, T. C., Savage, J. V., Palmer, P. S., & Moyer, R. W. (1988) · Microbial Pathogenesis · doi:10.1016/0882-4010(88)90060-5 · Cited by 13
Cited by
Viral and nonviral delivery systems for gene delivery
Nayerossadat, N., Maedeh, T., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 858
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407190-2.00007-1 · Cited by 594
Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carroll, M. W., Liu, C., Moss, B., Rosenberg, S. A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.277 · Cited by 493
Self-citationViral Vectors for Gene Transfer: A Review of Their Use in the Treatment of Human Diseases
Walther, W., & Stein, U. (2000) · Drugs · doi:10.2165/00003495-200060020-00002 · Cited by 442
Bisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 420
Self-citation
Metadata
- Authors
- Moss, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-10-15
- Volume
- 93
- Issue
- 21
- Pages
- 11341-11348
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1976215218
- Cited by
- 515
- References
- 91
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.